(Reuters) - Eli Lilly ( LLY ) investors and analysts said they want to hear details from the company on how exactly it plans to grow U.S. sales of popular weight-loss drug Zepbound after it last month forecast lower-than-expected fourth-quarter revenues for the drug. Lilly, which reports its fourth-quarter earnings on Thursday, said in January that wholesalers had not restocked...

WASHINGTON (Reuters) - U.S. banks and their regulators will be on the hot seat on Wednesday, as lawmakers explore claims from conservatives and some companies that they deny services to particular industries or political groups. The Senate Banking Committee will hold a hearing on what is commonly referred to as debanking, hearing testimony from subject matter experts and business owners...

* Musk's takeover causes panic among some federal workers * DOGE's creation faces lawsuits from unions and watchdogs * Trump sets out to restructure government By Tim Reid and Marisa Taylor WASHINGTON, Feb 5 (Reuters) - Elon Musk's rapid takeover of two U.S. government agencies has enabled the South African-born billionaire to exert unprecedented control over America's 2.2-million-member federal workforce...

* Banks argue rules, not ideology, hinder service provision * Republican-led states push for anti-discrimination banking laws By Pete Schroeder WASHINGTON, Feb 5 (Reuters) - U.S. banks and their regulators will be on the hot seat on Wednesday, as lawmakers explore claims from conservatives and some companies that they deny services to particular industries or political groups. The Senate Banking...